Pfizer to Buy Metsera for $4.9 Billion in Obesity-Drug Boost
Pfizer Inc. agreed to buy the obesity startup Metsera Inc. for an enterprise value of about $4.9 billion to bolster…
Pfizer Inc. agreed to buy the obesity startup Metsera Inc. for an enterprise value of about $4.9 billion to bolster…